Get the Stockscreener App
3.66
9.58%
0.32
After Hours:
3.47
-0.19
-5.19%
908 Devices Inc stock is traded at $3.66, with a volume of 195.11K.
It is up +9.58% in the last 24 hours and up +4.57% over the past month.
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.
See More
Previous Close:
$3.34
Open:
$3.37
24h Volume:
195.11K
Relative Volume:
1.14
Market Cap:
$126.84M
Revenue:
$50.23M
Net Income/Loss:
$-36.40M
P/E Ratio:
-3.0756
EPS:
-1.19
Net Cash Flow:
$-27.10M
1W Performance:
+10.24%
1M Performance:
+4.57%
6M Performance:
-35.22%
1Y Performance:
-44.38%
1-Day Range:
$3.27
$3.67
1-Week Range:
$3.13
$3.67
52-Week Range:
$3.13
$12.51
908 Devices Inc Stock (MASS) Company Profile
Name
908 Devices Inc
Sector
Industry
Phone
978-729-4478
Address
645 SUMMER STREET, BOSTON
908 Devices Inc Stock (MASS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-07-23 | Initiated | Stephens | Overweight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jan-12-21 | Initiated | Cowen | Outperform |
| Jan-12-21 | Initiated | SVB Leerink | Outperform |
| Jan-12-21 | Initiated | Stifel | Buy |
| Jan-12-21 | Initiated | William Blair | Outperform |
View All
908 Devices Inc Stock (MASS) Latest News
908 Devices (MASS) Scheduled to Post Earnings on Tuesday - MarketBeat
908 Devices to Participate in Upcoming Investor Conferences - BioSpace
908 Devices stock hits 52-week low at $3.24 amid market challenges - Investing.com Australia
908 Devices to Report Third Quarter 2024 Financial Results on November 12, 2024 - StockTitan
Investor presentation (10/21/2024 04: 00 - Marketscreener.com
908 Devices (NASDAQ:MASS) PT Lowered to $12.00 at Leerink Partners - Defense World
Leerink Partners Lowers 908 Devices (NASDAQ:MASS) Price Target to $12.00 - MarketBeat
Millennium Management LLC Increases Stock Holdings in 908 Devices Inc. (NASDAQ:MASS) - MarketBeat
908 Devices stock hits 52-week low at $3.35 amid market challenges - Investing.com
908 Devices Inc (MASS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges - Yahoo Finance
HazSim Enters South American Market with New Partner - Firehouse
908 Devices Inc. (NASDAQ:MASS) Shares Acquired by American Century Companies Inc. - Defense World
H1 in line with prelims; Guidance confirmed - Research Tree
908 Devices stock hits 52-week low at $3.44 amid market challenges - Investing.com
4D Molecular Therapeutics (NASDAQ:FDMT) Shares Gap Down to $11.90 - Defense World
Bel Fuse Inc. (NASDAQ:BELFA) Shares Sold by Gabelli Funds LLC - Defense World
BEL partners with Reliasat to explore space sector opportunities - Defence Watch
Cantor Fitzgerald Lowers 4D Molecular Therapeutics (NASDAQ:FDMT) to Neutral - MarketBeat
B4 Investimenti acquires majority stake in Italian SME Gruppo Ferper - Real Deals
BEL Partners with Reliasat to Explore Space Sector Opportunities - Indiainfoline
Rhumbline Advisers Acquires 787 Shares of Bel Fuse Inc. (NASDAQ:BELFB) - Defense World
Insider Stock Buyers At 908 Devices Recouped Some Losses This Week - Simply Wall St
$268 million BARDA deal for Basilea - The Pharma Letter
Safety Services Management expands illicit drug-contaminated vehicle cleaning services to Illinois - isStories
4D Molecular Therapeutics (NASDAQ:FDMT) Shares Down 14.4% - MarketBeat
BEL and Reliasat Ink Agreement to Propel Space Product Collaboration - Devdiscourse
Basilea scores $268M BARDA funding deal to work on antifungals, antibiotics - Fierce Biotech
4D Molecular Therapeutics (NASDAQ:FDMT) Trading 4.2% Higher - Defense World
Blackline Safety Boosts Detection of Gas, Gamma Radiation with Launch of Next-Gen Safety Monitor - Firehouse
908 Devices stock hits 52-week low at $3.45 amid market challenges - Investing.com
908 Devices Inc (MASS) Becoming More Attractive for Investors - Knox Daily
Best Workplaces for Innovators 2024: Biotech - Fast Company
908 Devices Inc. (NASDAQ:MASS) is favoured by institutional owners who hold 57% of the company - Yahoo Finance UK
908 Devices: Key Investor Now Selling (NASDAQ:MASS) - Seeking Alpha
Cathie Wood's ARK ETF adjusts portfolio, buys Tempus AI stock and sells Trade Desk - Investing.com UK
Mass Spectrometry Market to Grow by USD 3.52 Billion from 2024-2028, Driven by Hyphenated Technology and AI AdvancementsTechnavio Report - The Malaysian Reserve
908 Devices to Participate in Craig-Hallum Bioprocessing Conference - Business Wire
Staff Activation of Electronic Badges Saved Lives at Winder, GA, High School - Firehouse
908 Devices Inc [MASS] stock for 64,200 USD was acquired by Knopp Kevin J. - Knox Daily
908 Devices stock hits 52-week low at $3.9 amid market challenges - Investing.com
Startup Aims to Use Autonomous Helicopter to Fight Wildfires - Firehouse
MX908 Handheld Mass Spectrometer by 908 Devices - Firehouse
ProtectIR is Handheld Solid, Liquid Detection from 908 Devices - Firehouse
ThreatID from 908 Devices Identifies Powers, Liquids, Vaports - Firehouse
908 Devices Updates Investors with New Presentation - TipRanks
Investor presentation (08/30/2024 04: 00 - Marketscreener.com
XplorIR Handheld Gas Detector from 908 Devices - Firehouse
Investing in 908 Devices Inc (MASS): What You Must Know - Knox Daily
Thief Steals Rescue Tool from Call in Oakland, CA - Firehouse
908 Devices Releases New Hazmat Detection, ID Tool - Firehouse
Cathie Wood's ARK ETF adjusts portfolio, buys DraftKings, sells Genius Sports - Investing.com
908 Devices Inc Stock (MASS) Financials Data
Revenue
Net Income
Cash Flow
EPS
908 Devices Inc Stock (MASS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Eisenberg Marcia | Director |
Jun 07 '24 |
Option Exercise |
0.00 |
682 |
0 |
6,816 |
| Knopp Kevin J. | President and CEO |
May 13 '24 |
Buy |
6.42 |
10,000 |
64,200 |
508,981 |
| Knopp Kevin J. | President and CEO |
May 10 '24 |
Buy |
5.77 |
10,000 |
57,700 |
498,981 |
| Knopp Kevin J. | President and CEO |
May 09 '24 |
Buy |
5.83 |
10,000 |
58,300 |
488,981 |
| Knopp Kevin J. | President and CEO |
May 08 '24 |
Buy |
5.72 |
10,000 |
57,200 |
478,981 |
| Knopp Kevin J. | President and CEO |
May 07 '24 |
Buy |
5.60 |
10,000 |
56,000 |
468,981 |
| Knopp Kevin J. | President and CEO |
Apr 16 '24 |
Option Exercise |
1.75 |
47,000 |
82,250 |
458,981 |
| Brown Christopher D. | Chief Product Officer |
Apr 01 '24 |
Option Exercise |
1.75 |
3,600 |
6,300 |
884,994 |
| Griffith Joseph H. IV | Chief Financial Officer |
Mar 26 '24 |
Option Exercise |
1.58 |
8,437 |
13,330 |
93,437 |
| Griffith Joseph H. IV | Chief Financial Officer |
Feb 02 '24 |
Sale |
7.09 |
9,711 |
68,873 |
80,000 |
0.47%
1.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):